title: Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.
authors.affiliation: Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Bond
authors.affiliation: Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA.|Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX, USA.
authors.forename: Vaidehi J
authors.initials: VJ
authors.lastname: Thanawala
authors.affiliation: Vapogenix Inc., Houston, TX, USA.
authors.forename: Sergio
authors.initials: S
authors.lastname: Parra
authors.affiliation: Consultant in Pharmacology, Cheshire, UK.
authors.forename: Paul
authors.initials: P
authors.lastname: Leff
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001249:Asthma; D005260:Female; D008297:Male
chemical_list: D000319:Adrenergic beta-Antagonists